J&J Unit Challenges $12M Verdict While Competitor Seeks Additional Damages

By Editorial Team

A recent development in the legal battle between Johnson & Johnson subsidiary DePuy Synthes and RSB Spine has seen DePuy challenging a $12 million verdict for patent infringement. The dispute revolves around spinal fusion patents and the application of the doctrine of equivalents.

DePuy Synthes has contested the Delaware federal jury’s decision, claiming that the jury was mistaken in awarding $12 million to RSB Spine. The case involves patents related to intervertebral implants and bone plate stabilization systems.

On the other side, RSB Spine is pushing for an increase in damages. The company is seeking further financial compensation beyond the $12 million already awarded by the jury.

The legal battle has attracted significant attention within the intellectual property and life sciences sectors. Law firms involved in the case include Ashby & Geddes, Cooley LLP, Jones Day, and Phillips McLaughlin.

Key companies in the dispute include DePuy Synthes Cos., Johnson & Johnson, and RSB Spine. The case is being heard in the U.S. District Court for the District of Delaware.

The patents at the center of the dispute are numbered 7,846,207 for intervertebral implants and 9,713,537 for bone plate stabilization systems. Judge Richard G. Andrews is overseeing the case.